Health & bio

Stanford: 1 in 10 carry GLP-1 genetic resistance

Specific genetic variants blunt Ozempic and Wegovy response. Precision-medicine matching becomes critical.

Primary sources · 1
Stanford Med 4/2026
← View the full 2026-04-10 (Friday) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →